Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Meta-analysis of 25 observational studies (22 million participants): depressive (HR 1.40), anxiety (HR 1.63), sleep (HR 1.60) disorders and PTSD (HR 2.73) were associated with acute coronary syndrome; bipolar and psychotic disorders were not significantly.
Meta-analysisn = 22,048,504
Gupta et al. Mental Disorders as a Risk Factor of Acute Coronary Syndrome: A Systematic Review and Meta-AnalysisMeta-analysis of 20 RCTs (83,288 participants with type 2 diabetes or cardiometabolic disease): GLP-1 receptor agonists were not associated with a higher risk of optic nerve or vision-threatening events (OR 1.20, 95% CI 0.73-1.97).
Meta-analysisn = 83,288
Li et al. GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled TrialsNetwork meta-analysis of RCTs in acute schizophrenia (388 with usable data; 78,193 participants): all antipsychotics beat placebo on overall symptoms (SMD -0.90 to -0.23); clozapine, amisulpride, olanzapine and risperidone were among the most efficacious.
Meta-analysisn = 78,193
Schneider-Thoma et al. Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databasesMeta-analysis of 1,021 voxel-based morphometry experiments (29,540 patients, 28,177 controls) found strong evidence of selective grey matter reduction in the right middle temporal gyrus in bipolar disorder and posterior dorsal anterior cingulate in schizophrenia.
Meta-analysisn = 57,717
Liloia et al. Identification of a diagnosis-selective neurobiological substrate for bipolar disorder, major depressive disorder, and schizophrenia: a meta-analysis of 57,717 subjectsMulti-ancestry GWAS meta-analysis of 52,056 participants from 7 general population cohorts identified 361 genome-wide significant variants for decline in FEV1, FVC or FEV1/FVC; 4 (10.3% of those testable) replicated nominally in COPD-enriched cohorts.
Meta-analysisn = 52,056
Patchen et al. Multi-ancestry genome-wide association study and meta-analysis of lung function declineMeta-analysis of 205 studies (48,437 immunocompromised patients): pooled proportion with acute invasive fungal rhinosinusitis was 11.8% and mortality 31.2%, falling from 41.9% before 2013 to 28.2% after; morbidity was 37.0%.
Meta-analysisn = 48,437
Candelo et al. Proportion, Morbidity, and Mortality of Acute Invasive Fungal Rhinosinusitis in Immunocompromised Populations: A Systematic Review and Meta-analysisSystematic review and meta-analysis of 236 studies (25,278 adults with chronic airways disease): mean 5,494 steps/day and 48.2 min/day of MVPA, lowest in COPD and consistently below healthy controls; step count was associated with FEV1 % predicted and 6-min walk distance.
Meta-analysisn = 25,278
Griffiths et al. Physical inactivity in chronic airways disease: an important candidate in the treatable traits paradigmLong-term follow-up of the ASPREE trial in 19,114 older adults (median 8.6 years): low-dose aspirin was not associated with overall cancer incidence (HR 0.98) or colorectal cancer (HR 1.01), but was associated with higher cancer mortality (HR 1.15).
RCTn = 19,114
Orchard et al. Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSystematic review of 35 RCTs (10,824 adults): therapeutic smartphone apps vs waitlist or attention controls were associated with lower depression (MD −0.58) and anxiety (MD −0.56) scores, lower stress and higher well-being, with high heterogeneity.
Meta-analysisn = 10,824
Pasch et al. App-tivating progress: Smartphone apps for mental health relief: A systematic review and meta-analysisMeta-analysis of 26 RCTs (7452 patients) of neoadjuvant therapy for gastroesophageal adenocarcinoma: pathological complete response did not correlate with overall survival at individual (R² 0.006) or trial level (R² 0.060); subgroup surrogacy varied.
Meta-analysisn = 7,452
Leite et al. Is pathological complete response a surrogate for overall survival in neoadjuvant clinical trials for gastroesophageal adenocarcinoma?